Co-Authors
This is a "connection" page, showing publications co-authored by Conghui Wang and Jianwei Wang.
Connection Strength
1.333
-
Cross-reactive antibody against human coronavirus OC43 spike protein correlates with disease severity in COVID-19 patients: a retrospective study. Emerg Microbes Infect. 2021 Dec; 10(1):664-676.
Score: 0.245
-
SARS-CoV-2 nsp12 attenuates type I interferon production by inhibiting IRF3 nuclear translocation. Cell Mol Immunol. 2021 04; 18(4):945-953.
Score: 0.233
-
The kinetics of humoral response and its relationship with the disease severity in COVID-19. Commun Biol. 2020 12 11; 3(1):780.
Score: 0.229
-
High anal swab viral load predisposes adverse clinical outcomes in severe COVID-19 patients. Emerg Microbes Infect. 2020 Dec; 9(1):2707-2714.
Score: 0.229
-
Activation and evasion of type I interferon responses by SARS-CoV-2. Nat Commun. 2020 07 30; 11(1):3810.
Score: 0.224
-
Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study. Lancet. 2021 03 20; 397(10279):1075-1084.
Score: 0.058
-
N6-methyladenosine regulates RNA abundance of SARS-CoV-2. Cell Discov. 2021 Jan 28; 7(1):7.
Score: 0.058
-
Humanized single domain antibodies neutralize SARS-CoV-2 by targeting the spike receptor binding domain. Nat Commun. 2020 09 10; 11(1):4528.
Score: 0.056